From Premium to Therapeutic: How a Super-Premium Pet Food Brand Used Bespoke Research and Consulting to Decide Whether to Enter the Veterinary Therapeutic Nutrition Segment
Executive Snapshot
Client
Situation/Challenge
Objective
Constancy Researchers Solution
Impact
Client Outcome
The Situation / Challenge
The line between super-premium pet food and veterinary therapeutic nutrition looks thinner than it is. Both involve high-quality ingredients, condition-specific formulations, and health-oriented messaging.
The client’s innovation team had developed its therapeutic formulations with genuine scientific rigour and believed the product quality would be self-evident to veterinary professionals. What the team had not fully examined was how veterinary gatekeepers in the therapeutic nutrition segment evaluated new entrants, and specifically whether product quality alone was sufficient to displace existing recommendation relationships with brands that had clinical trial literature, veterinary nursing education programmes, and established practice-level distribution agreements backing them.
The CEO’s concern was not that the products were wrong. It was that the entry model might be wrong, and that committing the commercial and regulatory investment required for a credible veterinary channel entry might produce a return that the brand’s direct-to-consumer strengths could have generated at lower cost through a different route.
Key Challenges
- No bespoke research into the competitive dynamics and veterinary recommendation structures specific to the therapeutic nutrition segment the client was planning to enter.
- No assessment of the clinical validation evidence requirements that veterinary gatekeepers applied when evaluating new therapeutic nutrition brands.
- An innovation team confident in product quality without independent evidence of how veterinary recommendation decisions were actually made in this segment.
- No analysis of whether the client’s clean-label positioning carried meaningful weight in veterinary recommendation decisions relative to clinical trial evidence.
- A significant commercial and regulatory investment required for credible veterinary channel entry that the CEO wanted tested against the realistic return before committing.
- An alternative direct-to-consumer functional nutrition route not fully evaluated against the therapeutic channel opportunity.
Super-premium and veterinary therapeutic are adjacent in the retail display sense but structurally different in the decision-making sense. The pet owner who chooses a super-premium food based on ingredient quality is exercising their own judgement. The pet owner who feeds a therapeutic diet is following a veterinary recommendation. Reaching the second pet owner requires winning a veterinary relationship, not a consumer one, and that is a different marketing infrastructure from the one that built the brand.
Constancy Researchers Solution
Constancy Researchers designed the bespoke research to answer the channel access question specifically, examining not just whether the therapeutic segment was commercially attractive but whether the client had the right assets to compete in it credibly.
Veterinary Therapeutic Nutrition Segment Competitive Landscape Research
- Conducted bespoke research into the veterinary therapeutic nutrition segment, mapping the competitive positions of established players.
- Found the segment dominated by two global players whose veterinary recommendation relationships were supported by extensive peer-reviewed clinical trial evidence.
Veterinary Gatekeeper Recommendation Decision Research
- Researched how veterinary professionals evaluated and recommended therapeutic nutrition brands, examining the weight they placed on clinical trial evidence, formulation data.
- Found that peer-reviewed clinical trial evidence was the primary decision criterion cited by veterinary professionals when recommending a therapeutic diet.
Client Brand Positioning Assessment for Therapeutic Channel
- Assessed the client’s existing brand assets against the recommendation criteria the research had identified, examining whether its clinical validation investment.
- Found significant gaps in all three areas: the client had no published clinical trial evidence for its therapeutic formulations.
Alternative Route Assessment: Direct-to-Consumer Functional Nutrition
- Assessed the direct-to-consumer functional nutrition positioning as an alternative entry route.
- Found that a direct-to-consumer functional nutrition positioning around renal support, weight management, and digestive sensitivity.
Entry Model Recommendation & Investment Comparison
- Delivered a comparative investment and return analysis contrasting the multi-year clinical validation and channel development investment required for credible veterinary therapeutic entry against the shorter route to revenue through direct-to-consumer functional nutrition.
The engagement gave the CEO a specific, evidence-grounded comparison of both routes, confirming the therapeutic channel opportunity was real but that the brand’s existing assets were better positioned for a different path to the same pet owner demand.
Impact
- Bespoke research confirmed the veterinary therapeutic segment was dominated by two players with clinical trial evidence and practice-level distribution the client did not have.
- Veterinary gatekeeper research found clinical trial evidence was the primary recommendation criterion, with clean-label positioning carrying limited additional weight.
- The client brand assessment identified gaps in clinical validation, veterinary liaison capability, and practice distribution for credible therapeutic channel entry.
- The direct-to-consumer functional nutrition route was identified as able to reach condition-specific demand without the clinical validation investment.
- A comparative investment and return analysis confirmed the functional nutrition route offered faster and more capital-efficient revenue access.
- The CEO deprioritised the veterinary therapeutic channel for the current funding cycle.
- Two functional nutrition product lines launched within twelve months targeting renal support and weight management.
- The functional nutrition launch leveraged the brand’s existing clean-label positioning and direct-to-consumer distribution without requiring a new channel infrastructure.
Client Outcome
Strategic Reorientation
The veterinary therapeutic channel was deprioritised in favour of a direct-to-consumer functional nutrition route better matched to the brand's existing assets.
Faster Market Entry
Two functional nutrition lines launched within twelve months, reaching condition-specific pet owner demand without the multi-year clinical validation investment.
Capital Efficiency
The therapeutic channel's multi-year entry investment was avoided in favour of a route that leveraged existing brand and distribution infrastructure.
Brand Fit Confirmed
Clean-label and high-protein positioning was confirmed as a genuine differentiator in the functional nutrition consumer channel.
Channel Clarity
The gap between the client's existing assets and the requirements for credible veterinary channel entry was quantified, providing a roadmap for potential future therapeutic entry.
CEO Confidence
A structured, evidence-based route comparison replaced an innovation team advocacy case as the basis for the channel investment decision.
Competitive Intelligence
The bespoke research produced a detailed picture of how the segment's dominant players had built their veterinary recommendation positions.
Future Pathway Defined
The clinical validation gap assessment provided a specific investment roadmap for a credible veterinary channel entry if the brand chose to pursue it in a future cycle.
Market Positioning
The brand was repositioned as a functional pet nutrition leader in its natural consumer channel rather than a premium challenger in a segment its current assets were not built to enter.
Case Studies
Learn how our success stories power data-driven growth across industries
Fewer Stampings, Different Stampings: How a Metal Forming Toolmaker Used Market Research and Strategy Advisory to Navigate the EV Transition’s Impact on Its Stamping Die Business
Executive Snapshot Client Automotive Stamping Die Manufacturer, Bavaria, Germany Situation/Challenge...
Read MoreStopping the Stops: How an Automotive Parts Manufacturer Used Consulting and Analytics to Identify the Real Causes of Unplanned Downtime Across Its Horizontal Machining Centre Fleet
Executive Snapshot Client Tier-Two Automotive Parts Manufacturer, Czech Republic Situation/Challenge...
Read MoreFull Shop, Empty Machine: How a Steel Fabrication Business Used Market Research and IDIs to Understand Why Its Plasma Cutting Capacity Was Underused Despite Strong Demand in the Market
Executive Snapshot Client Structural Steel Fabricator, Ohio, United States Situation/Challenge...
Read More